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Agrin induces, whereas acetylcholine (ACh) dis-
perses, ACh receptor (AChR) clusters during
neuromuscular synaptogenesis. Such counter-
active interaction leads to eventual dispersal
of nonsynaptic AChR-rich sites and formation
of receptor clusters at the postjunctional mem-
brane. However, the underlying mechanisms
are not well understood. Here we show that
calpain, a calcium-dependent protease, is acti-
vated by the cholinergic stimulation and is
required for induced dispersion of AChR clus-
ters. Interestingly, the AChR-associated protein
rapsyn interacted with calpain in an agrin-de-
pendent manner, and this interaction inhibited
the protease activity of calpain. Disrupting
the endogenous rapsyn/calpain interaction
enhanced CCh-induced dispersion of AChR
clusters. Moreover, the loss of AChR clusters
in agrin mutant mice was partially rescued by
the inhibition of calpain via overexpressing
calpastatin, an endogenous calpain inhibitor,
or injecting calpeptin, a cell-permeable calpain
inhibitor. These results demonstrate that cal-
pain participates in ACh-induced dispersion of
AChR clusters, and rapsyn stabilizes AChR
clusters by suppressing calpain activity.
INTRODUCTION
Neuromuscular synapses are formed betweenmotor neu-
rons and skeletal muscle fibers. AChRs are concentrated
at the postsynaptic membrane, which guarantees efficient
and accurate neurotransmission. AChR clustering is a
dynamic process, whereby nascent clusters underneath
nerve terminals are stabilized by agrin, a motor-neuron-
derived glycoprotein, and the AChR-associated proteinrapsyn (McMahan, 1990; Sanes and Lichtman, 1999,
2001). Meanwhile, motor neurons release negative signals
to disperse noninnervated clusters and refine clusters at
the synapses.Genetic studies suggest that AChmay serve
as a negative signal. AChR clusters are larger in mice de-
ficient in choline acetyltransferase (ChAT), the key enzyme
for ACh synthesis, and numerous AChR clusters are main-
tained in ChAT and agrin double mutant mice (Lin et al.,
2005; Misgeld et al., 2002, 2005), whereas few AChR clus-
ters are present in the muscle of agrin single mutant mice
(Burgess et al., 1999; Gautam et al., 1996; Lin et al., 2001;
Yang et al., 2001). The interplay between positive and neg-
ative signals is necessary for precise matching of nerve
terminals to individual postsynaptic apparatuses (Sanes
and Lichtman, 1999, 2001).
Recent evidence suggests that Cdk5, a cytoplasmic
serine/threonine kinase, may be an effector in dispersing
or refining AChR clusters. ACh activates Cdk5, and inhibi-
tion of Cdk5 by genetic ablation or pharmacological inhibi-
tion increases AChR cluster size in cultured muscle fibers
and in mutant mice (Fu et al., 2005; Lin et al., 2005). The
dispersing activity of ACh can be counteracted by agrin
(Lin et al., 2005; Misgeld et al., 2005), presumably via the
activation of MuSK, a muscle-specific tyrosine kinase
receptor concentrated in the postsynaptic region of neu-
romuscular junctions (Glass et al., 1996). Thus, the overall
inhibitory effect by ACh and Cdk5 is reversed locally by
agrin signaling so that AChR clusters are stabilized at the
neuromuscular junction (NMJ). Rapsyn is believed to be
required for agrin-induced AChR clustering and stabiliza-
tion (Apel et al., 1997; Froehner, 1991; Fuhrer et al., 1999;
Gautam et al., 1996; Phillips et al., 1997). However, the
effectors of rapsyn are not well defined. Here we provide
evidence that rapsyn acts by inhibiting calpain to regulate
AChR cluster stabilization at the NMJ.
Calpains are a family of calcium-activated intracellular
cysteine proteases, which are ubiquitously expressed in
various mammalian cells (Goll et al., 2003). In the brain,
calpains are involved in many physiological events includ-
ing LTP (Carafoli and Molinari, 1998; Oliver et al., 1989;
Staubli et al., 1988) or neurotoxic insults ranging fromNeuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 247
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Rapsyn Inhibits CalpainFigure 1. Activation of Calpain by Cho-
linergic Agonist
(A) Activation of calpain by stimulationwith car-
bachol (CCh). C2C12 myotubes were treated
with CCh (0.1 mM), without or with 20 mM cal-
peptin for the indicated times. The activity of
calpain in cell lysates was measured using
Suc-Leu-Tyr-AMC as the substrate. The value
of control cells was taken as 1.0. Data are
shown as mean ± SEM (n = 3). ***p < 0.001,
CCh versus CCh + calpeptin at each time point.
(B) Accumulation of p25 in CCh-treatedmuscle
cells. C2C12 myotubes were treated without
(control) or with 0.1mMor 1mMCCh for the in-
dicated times. Lysates (30 mg of protein) were
subjected to immunoblotting with antibodies
against p35 or b-actin.
(C and D) Dependence of CCh-induced Cdk5
activation on calpain activity. C2C12myotubes
were treated with or without calpeptin (20 mM)
for 2 hr prior to incubation with CCh (0.1 mM)
for additional 5 hr. The activity of Cdk5 purified
by immunoprecipitation was assayed in vitro
using histone H1 as substrate in the presence
of [g-32P]-ATP. Normalized Cdk5 activity was
summarized in (D), where Cdk5 activity of con-
trol cells was taken as 1.0. Data are shown as
mean ± SEM (n = 3; ***p < 0.001, Student’s
t test).ischemia to Alzheimer’s disease (Lee et al., 2000; Nixon,
2000; Patrick et al., 1999). A number of proteins have
been identified as calpain substrates from various tissues
(Goll et al., 2003). Calpain cleavage of p35, a regulatory
partner of Cdk5, generates p25, which causes hyperacti-
vation of Cdk5 (Ahlijanian et al., 2000; Patrick et al., 1999;
Patzke et al., 2003). Transient expression of p25 in the hip-
pocampus enhances LTP and facilitates hippocampus-
dependent memory, whereas prolonged p25 expression
results in loss of synapses and death of neurons (Fischer
et al., 2005).
In the present study, we demonstrate a role of calpain in
regulating postsynaptic differentiation at the NMJ. The
cholinergic stimulation increased calpain activity, and
this in turn resulted in an accumulation of p25, a potent ac-
tivator of Cdk5. Inhibition of calpain attenuated cholinergic
agonist-induced dispersal of AChR clusters in cultured
muscle cells and prevented the loss of AChR clusters in
agrin mutant mice. We also investigated regulatory mech-
anisms of calpain activity and found that rapsyn interacted
with calpain and inhibited the cleavage activity of calpain.
Together these studies identify a critical signaling mecha-
nism by which ACh destabilizes AChR clusters and reveal
a function of rapsyn in regulating AChR clustering and
NMJ formation.
RESULTS
Activation of Calpain by the Cholinergic Agonist
Carbachol
The activity of calpain is known to be regulated by calcium
(Carafoli and Molinari, 1998; Glading et al., 2002; Goll248 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.et al., 2003). It has been shown that cholinergic stimulation
or depolarization of muscle cells causes calcium elevation
(Allard et al., 1996; Cherednichenko et al., 2004). We in-
vestigated whether cholinergic stimulation regulates cal-
pain activity in muscle cells. As shown in Figure 1A, treat-
ment with carbachol (CCh), a nonhydrolyzable cholinergic
agonist that triggers Ca2+ transients in muscle cells (data
not shown), caused an increase of calpain activity in
C2C12 myotubes; the activity peaked 15 min after CCh
stimulation and declined thereafter. The CCh-induced ac-
tivation of calpain was attenuated when muscle cells were
pretreated with calpeptin, a cell-permeable calpain inhib-
itor. These results demonstrate that cholinergic stimula-
tion increases calpain activity in muscle cells. Cdk5 in
muscle cells can be activated by ACh (Lin et al., 2005),
although exactmechanisms remain unclear. p35 is a regu-
latory partner of Cdk5 and a specific substrate of calpain
(Kusakawa et al., 2000; Lee et al., 2000; Nath et al.,
2000). Proteolytic cleavage of p35 by calpain generates
p25, which causes hyperactivation of Cdk5 (Fischer
et al., 2005; Kusakawa et al., 2000; Lee et al., 2000; Patrick
et al., 1999). We investigated whether CCh regulates p25
production. As shown in Figure 1B, the amount of p25 in-
creased in C2C12 myotubes treated with CCh. By con-
trast, the level of p35 appeared to be constant, probably
due to rapid turnover rates and the addition of newly syn-
thesized p35 (O’Hare et al., 2005; Patrick et al., 1998). The
CCh-induced p25 accumulation was suppressed in mus-
cle cells that were pretreated with calpeptin (Figure 1C,
lane 3 and 4), suggesting the specific role of calpain in
p25 production. To investigate the function of calpain-me-
diated p25 production, we evaluated the consequence of
Neuron
Rapsyn Inhibits Calpaincalpain inhibition on Cdk5 kinase activity. CCh treatment
induced a robust increase in [32P]-labeled histone H1, in-
dicative of Cdk5 activation, consistent with a previous
study (Lin et al., 2005) (Figures 1C and 1D). Interestingly,
CCh-induced Cdk5 activation was inhibited by calpeptin
(Figures 1C and 1D), suggesting a role of calpain in cholin-
ergic agonist-induced Cdk5 activation.
Increased AChR Cluster Stability
by Calpain Inhibition
Next we investigated whether calpain was involved in cho-
linergic agonist-induced dispersion of AChR clusters.
C2C12 myotubes were first treated with agrin to induce
AChR clusters, and then switched to agrin-free medium
in the presence of CCh with or without calpeptin. CCh
treatment promoted disassembly of AChR clusters by re-
ducing both total length and number of clusters (Figures
2A–2C). This result is in agreement with the earlier reports
that CCh destabilizes AChR clusters (Lin et al., 2005;
Misgeld et al., 2005). The reduction in AChR clusters by
CCh was ameliorated in calpeptin-treated cells (Figures
2B and 2C), suggesting that calpain may participate in
‘‘cholinergic’’ agonist-induced dispersal of AChR clusters.
To further examine the role of calpain in regulating AChR
clusters, we suppressed calpain expression by small inter-
ference RNA (siRNA). Because m- but not m-calpain is the
dominant form expressed in C2C12 cells and in skeletal
muscles (data not shown), we screened several siRNA
sequences and identified calpain-siRNA (CP-siRNA) that
could suppress the expression of endogenous m-calpain
effectively (Figure2D).Similar to the treatmentwith calpep-
tin, transfection with calpain-siRNA prevented the disper-
sion of AChR clusters by CCh (Figures 2E and 2F). These
results support the notion that calpain is involved in ‘‘cho-
linergic’’ stimulation-induced dispersal of AChR clusters.
Rapsyn Interaction with Calpain
Interestingly, when using rapsyn as bait to search for bind-
ing proteins in yeast two-hybrid screens, we identified the
large subunit of m-calpain. m-Calpain is composed of two
subunits: a distinct 80 kDa large subunit, and a small sub-
unit (28 kDa) that is shared with m-calpain (Carafoli and
Molinari, 1998; Goll et al., 2003; Sorimachi et al., 1997).
The large subunit contains four domains: a short pro-
domain (domain I) in the N-terminus, a catalytic protease
domain (domain II), a regulatory domain (domain III), and
a calcium-binding domain (domain IV) containing EF hand
motifs (Glading et al., 2002; Goll et al., 2003). The original
clone isolated from yeast contained 266 residues (aa 435–
700) covering a partial domain III and domain IV, suggest-
ing that the binding region resides in domains III and IV
(Figure 3B). To map the domain necessary for the interac-
tion, Myc-tagged domains III (Myc-DIII) or IV (Myc-DIV)
was coexpressed with HA-rapsyn in HEK293 cells. Immu-
noprecipitation (IP) of rapsyn resulted in co-IP of m-cal-
pain domain III, but not domain IV, indicating that rapsyn
is associatedwithm-calpain via domain III, but not domain
IV (Figure 3C).Rapsyn contains seven tetratricopeptide repeat (TPR)
domainsmediating self-association (Ramarao et al., 2001;
Ramarao and Cohen, 1998), one coiled-coil domain bind-
ing to the AChR (Bartoli et al., 2001; Ramarao et al., 2001),
and a RING domain interacting with b-dystroglycan (Bar-
toli et al., 2001) (Figure 3A). To determine which region
in rapsyn interacts with calpain, a series of constructs en-
coding different rapsyn fragments were expressed in
HEK293 cells. Cell lysates were incubated with His-m-
calpain immobilized on beads. Constructs that contained
the TPR domains (the full-length rapsyn and rapsyn1–320)
associated with His-m-calpain (Figure 3D). However, the
coiled-coil domain and the RING domain were barely de-
tectable in the precipitates. These results indicate that the
TPR domains in rapsyn mediate interaction with calpain.
Similar results were obtained in co-IP experiments (Fig-
ure 3E). The interaction and domain mapping results are
summarized in Figure 3B. The rapsyn-calpain interaction
did not appear to be regulated by calcium, since the asso-
ciation was unchanged by the addition or depletion of
calcium (Figure 3F).
Inhibition of Calpain Activity by Rapsyn
The catalytic activity of calpain can be regulated through
the interaction of domain III with calcium, phospholipids,
and/or regulatory proteins (Benetti et al., 2001; Glading
et al., 2002; Tompa et al., 2001). In light of its interaction
through domain III with rapsyn, we reasoned that the latter
might regulate calpain’s activity. To test this possibility,
calpain activity in mouse brain lysates was assayed
in vitro, with p25 production as readout, in the absence
or presence of GST-rapsyn. Calpain was activated by
calcium, which promotes the cleavage of p35 to p25
(Figure 4A, lane 2) (Ahlijanian et al., 2000; Patrick et al.,
1999; Patzke et al., 2003). This proteolytic activity was in-
hibited by calpeptin, indicating the specificity (Figure 4A,
lane 4). Remarkably, GST-rapsyn, but not GST, inhibited
p35 cleavage and p25 production (Figure 4A, lane 3), sug-
gesting that rapsynmight inhibit calpain activity. To exam-
ine whether rapsyn regulates calpain activity in cells, p35-
Myc was cotransfected with rapsyn-EGFP or EGFP in
HEK293 cells (Figure 4B). Transfected cells were treated
with ionomycin, a calcium ionophore that causes calcium
influx to activate calpain (Croall, 1989). Treatment with ion-
omycin resulted in the p35 cleavage and p25 production
(Figure 4B, lane 2). However, ionomycin-induced p35
cleavage and p25 production were inhibited in cells ex-
pressing rapsyn (Figure 4B, lane 1). To further evaluate
the role of rapsyn in regulating calpain activity in muscle
cells,weexplored theconsequenceof suppressing rapsyn
expression. Two rapsyn-siRNAs (#233 and #270) were
generated and transfected into HEK293 cells. siRNA-
233, but not control siRNA, suppressed exogenous ex-
pressed rapsyn in HEK293 cells and endogenous rapsyn
in C2C12 muscle cells (Figures 4C and 4G). However, the
effect of siRNA-270 was minimal, if any (Figure 4C), and
was thus not used in the following experiments. Transfec-
tion of muscle cells with siRNA-233 had no effect onNeuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 249
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Rapsyn Inhibits CalpainFigure 2. Cholinergic Agonist-Induced Dispersion of AChR Clusters Is Attenuated by Calpain Inhibition or Downregulation
(A) Increased stability of AChR clusters in calpeptin-treated muscle cells. C2C12 myotubes were stimulated with agrin (10 ng/ml, 12 hr) to induce
AChR clusters and switched to agrin-free medium containing 0.1 mM CCh, either alone or together with calpeptin (20 mM), and incubated for
1–3 hr. AChR clusters were visualized by R-BTX. Shown are images from a representative experiment that was repeated three times with similar
results. Scale bar, 50 mm.
(B and C) Total length (B) and number of clusters bigger than 5 mm in length (C) per 100 mm myotube were quantitatively analyzed. The value from
DMSO-treated cells after agrin withdrawal was used as control. Data are shown as mean ± SEM from at least three experiments (***p < 0.001 in com-
parison to control, Student’s t test). The following number of myotubes was scored: 226 for control, 198 for calpeptin, 278 for CCh, and 233 for CCh +
calpeptin.
(D) Downregulation of m-calpain expression inmuscle cells by siRNA. C2C12 cells transfected with parental plasmid pSUPER-EGFP or that encoding
siRNA of m-calpain (CP-siRNA) were lysed, and resulting lysates were probed for m-calpain levels with b-actin as control.
(E) Increased stability of AChR clusters in muscle cells transfected with CP-siRNA. C2C12 myoblasts transfected with control or CP-siRNA plasmids
were induced for differentiation 12 hr after transfection. After treatment with agrin for 12 hr, myotubes were switched to agrin-free medium without or
with CCh (0.1 mM) and incubated for 1 hr. AChR clusters were visualized by R-BTX. Coexpressed GFP was used to show cell morphology.
(F) Total length of AChR clusters per 100 mm transfectedmyotube. Data are presented asmean ± SEM of three independent experiments. At least 100
myotubes were analyzed for each condition. ***p < 0.001, in comparison to control cells after agrin withdrawal.calpain expression, but elevated p25 levels in control and
CCh-treated myotubes (Figure 4D). These results indicate
that suppression of rapsyn expression increases calpain
activity, in line with the notion that rapsyn inhibits calpain
activity in vitro.
Inhibition of Calpain by Agrin in Muscle Cells
Since rapsyn is required for AChR clustering (Apel et al.,
1997; Froehner, 1991; Fuhrer et al., 1999; Gautam et al.,250 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.1995; Phillips et al., 1997), we asked whether agrin regu-
lates the interaction between rapsyn and calpain. First,
we investigated whether rapsyn and calpain interact
in vivo, which was analyzed by IP experiments in control
and agrin-stimulated C2C12 myotubes (Figure 4E). IP of
rapsyn resulted in co-IP of calpain (Figure 4E, lane 3). By
contrast, calpain was not detectable in precipitates with
a control antibody (Flag) or in a reaction when the anti-
bodies were omitted (No Ab) (Figure 4E, lane 1 and 2),
Neuron
Rapsyn Inhibits CalpainFigure 3. Rapsyn Interacts with Calpain
(A) Schematic structure of rapsyn domains.
(B) Identification of domains in calpain necessary for interaction with rapsyn. Data were summarized from yeast two-hybrid, coimmunoprecipitation
(CoIP), and pulldown assays. +, positive interaction; , no interaction; ND, not detected.
(C–E) Calpain domain III associates with rapsyn TPR domains. HEK293 cells coexpressing HA-rapsyn proteins and/or Myc-tagged calpain domains
were lysed. Resulting lysates were subjected to IP with antibodies against rapsyn (C) or Myc (E) and subsequent immunoblotting (IB) with indicated
antibodies. IgG H, IgG heavy chain; IgG L, IgG light chain; NSP, nonspecific protein. The asterisks indicate positive interacting bands. (D) The lysates
of HEK293 cells transfected with HA-tagged rapsyn were incubated with His-tagged calpain large subunit immobilized on Ni-NTAmetal affinity resin.
Bound proteins were probed with anti-HA antibody.
(F) The rapsyn-calpain interaction is not regulated by calcium. C2C12 cells were lysed in the modified RIPA buffer containing 5 mM EGTA or 5 mM
Ca2+, respectively. Lysates were incubated with GST-rapsyn or GST immobilized on glutathione-sepharose beads. Bound proteins were subjected to
IB with anti-calpain antibody.indicating the specificity of the interaction. The interaction
between rapsyn and calpain was increased by 2.5-fold in
agrin-treated C2C12 myotubes (Figure 4E, histogram).
Quantitative analysis showed that in the absence of agrin,
12% of calpain in C2C12 myotubes interacted with rap-
syn, whereas the amount of rapsyn-interacting calpain in-
creased to 30% in response to agrin stimulation (see
Figure 4 legend for detailed calculation). Since rapsyn is
associated with AChR and this association is increased
upon agrin stimulation (Moransard et al., 2003), we exam-
ined whether calpain is in the complex of AChR. As shown
in Figure 4F, IP with antibody against AChR alpha subunit
(AChRa) resulted in co-IP of m-calpain, as well as rapsyn.
The association of AChR with m-calpain or rapsyn was in-
creased upon agrin stimulation (Figure 4F, lanes 4 and 6).
These associations were specific, since IPwith control an-
tibody did not show any positive bands (Figure 4F, lanes 3
and 5). In line with the notion that m-calpain associateswith rapsyn and AChRs, m-calpain was found to be colo-
calized with AChRs at the NMJ (Figure S1 in the Supple-
mental Data available with this article online).
The observation that agrin increased the rapsyn-calpain
interaction raised the possibility that agrin might regulate
calpain’s activity in muscle cells. We found that CCh-in-
duced accumulation of p25 was decreased when the cells
were pretreated with agrin (Figure 4G, lanes 1–3), sug-
gesting an inhibitory role of agrin in calpain activity. The in-
hibitory effect of agrin requires rapsyn, since downregula-
tion of rapsyn in muscle cells prevented agrin from
suppressing CCh-induced p25 elevation (Figure 4G, lane
4). In addition, CCh-induced increase of calpain activity
was also suppressed by agrin (Figure 4H). Taken together,
these results suggest that agrin may inhibit calpain activity
by increasing the rapsyn-calpain interaction. To further
explore the regulation of calpain in vivo, we compared
the calpain activity between synaptic and nonsynapticNeuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 251
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Rapsyn Inhibits CalpainFigure 4. Regulation of Calpain Activity by Rapsyn and Agrin
(A) Inhibition of brain calpain activity by rapsyn. Rat brain lysates were incubatedwithout (control) or with 5mMCa2+. The calpain activity in the lysates
was assayed by measuring the level of p25, which was revealed by IB. In some experiments, lysates were incubated with calpeptin (20 mM), GST
(2 mg), or GST-rapsyn (2 mg).
(B) Rapsyn inhibits calpain activity in cells. HEK293 cells transfected with p35-myc and rapsyn-EGFP or EGFP were treated with ionomycin for 1 hr.
The cell lysates were probed with indicated antibodies.
(C) Suppression of rapsyn expression by siRNA. HEK293 cells were transfected with HA-rapsyn and EGFP, together with control or rapsyn-siRNA233
or -270. Lysates were probed with antibodies against HA or GFP.
(D) Increase in p25 production in C2C12 cells transfected with rapsyn-siRNA-233. C2C12 myotubes were transfected with control siRNA or siRNA-
233. Differentiated myotubes were treated with CCh (0.1 mM, 5 hr), and the level of p25 or m-calpain was probed.
(E) Increased interaction of rapsyn with calpain in agrin-stimulated muscle cells. C2C12 myotubes were treated with or without agrin (10 ng/ml, 8 hr).
Lysates were subjected to IP with monoclone anti-rapsyn or anti-Flag (control) antibodies. Resulting immunocomplexes were probed with antibodies
against m-calpain or rapsyn. Five percent of inputs were loaded to quantitate the efficacy of IP. Since only1%or 2.5%of calpain was coprecipitated
with rapsyn in the absence or presence of agrin, respectively, and 8% rapsyn was IP-ed, the total amount of m-calpain that was associated with
rapsyn should be12-fold (100/8) of that seen in the blots, i.e.,12% (1% times 12) and30% (2.5% times 12), before and after agrin stimulation.
Quantitative analysis of data is shown in the histogram. The amount of rapsyn-associated m-calpain without agrin treatment was taken as 1.0. Data
are shown as mean ± SEM (n = 3).
(F) Increased association of calpain with the AChR/rapsyn complex. C2C12 myotubes were treated as in (E), and resulting lysates were IP-ed with
antibody against AChRa. AChR-associated m-calpain or rapsyn was probed.
(G) Reduced p25 accumulation in agrin-stimulatedmuscle cells. C2C12myoblastswere transfectedwith siRNA-233 (lane 4) or control siRNA (lane 1–3),
then induced for differentiation 12 hr after transfection. Resulting myotubes were treated with or without agrin (10 ng/ml, overnight) prior to CCh
exposure (0.1 mM, 5 hr). Cell lysates were subjected to IB with indicated antibodies.
(H) Inhibition of CCh-induced calpain activity by agrin treatment. C2C12 myotubes were pretreated without or with agrin (10 ng/ml, 15 min) before
exposure to CCh (0.1 mM, 30 min). Calpain activity was determined using Suc-Leu-Tyr-AMC as the substrate. Data are shown as mean ± SEM (n = 3;
***p < 0.001, Student’s t test).
(I) Comparison of p25 levels in synaptic and nonsynaptic regions. Different parts of diaphragm (SR, synaptic region covered by phrenic nerve; NSR,
marginal region of muscle distant from nerve branches) were dissected out. Same amount of homogenates (100 mg protein) from NSR or SR was
subjected to IB. The relative level of indicated proteins was marked underneath each blot by taking the value of NSR as 1.0. The level of p25 reflects
relative activity of calpain in different regions of the muscle.regions (Figure 4I, left) in the skeletal muscle by examining
levels of p25 and calpain in these regions. As shown in Fig-
ure 4I, the level of rapsyn or AChRa is several-fold higher in252 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.synaptic region (SR) than in nonsynaptic region (NSR).
However, the level of m-calpain appeared to be similar
between NSR and SR regions. m-calpain was barely
Neuron
Rapsyn Inhibits CalpainFigure 5. Disruption of the Rapsyn-Calpain Interaction Decreases AChR Cluster Stability
(A) Disruption of the rapsyn-calpain interaction by calpain domain III. C2C12 myoblasts were transfected with rapsyn-EGFP, without or with Myc-DIII
or DIV. Cell lysates of transfected myotubes were subjected to IP with antibodies against GFP, followed by IB with indicated antibodies.
(B) Overexpression of calpain domain III elevates CCh-induced p25 accumulation. Transfected C2C12 myotubes were treated with CCh (0.1 mM,
5 hr). Amounts of transfected calpain fragments or endogenous p25 were probed.
(C and D) The effects of calpain mutants on agrin-induced AChR clustering. C2C12 myoblasts were transfected with the empty vector (pCS2 + MT)
or that encoding DIII, or -DIV. Resulting myotubes were stimulated with agrin (10 ng/ml, 12 hr) to induce AChR clusters. The number and total length
of AChR clusters per 100 mm myotube were shown in (C) and (D), respectively. Data are shown as mean ± SEM from three experiments (*p < 0.05,
**p < 0.01, Student’s t test). The following numbers of transfected-myotubes were analyzed: 77 for pCS2, 83 for DIII, and 116 for DIV.
(E) AChR cluster stability in muscle cells expressing calpain proteins in the absence or presence of roscovitine (Ros). C2C12 cells were transfected
with pCS2 + MT or calpain constructs, and the transfected myotubes were treated with agrin as in (C) and (D), followed by exposure to agrin-free
medium for 2 hr in the presence of CCh (0.1 mM) (top four sets in [E]) or of CCh (0.1 mM) plus Ros (10 mM) (bottom four sets in [E]). The myotubes
from these two treatments that have been stained with R-BTX or anti-Myc antibodies (red and green fluorescence, respectively). Scale bar, 25 mm.
(F–I) Quantitative analysis of total length (F andG) and number (H and I) of AChRclusters per 100 mmMyc-positivemyotube. Data are shown asmean ±
SEM from three experiments (***p < 0.001 in comparison with control, Student’s t test). The following numbers of transfected-myotubes were scored:
90 for pCS2 + MT (control), 147 for calpain, 145 for DIII, 104 for DIV.detectable in the diaphragm muscle (data not shown). In-
terestingly, the level of p25 in SR was only 60% of that
in NSR (Figure 4I, right), suggesting that calpain is locally
inhibited at the NMJ, probably by agrin and rapsyn.
Disruption of the Rapsyn-Calpain Interaction
Increases Calpain Activity and Promotes
CCh-Induced Dispersion of AChR Clusters
To evaluate the role of the rapsyn-calpain interaction in
AChR clustering, we sought to disrupt such interaction
in muscle cells. Sufficient to bind to rapsyn, domain III
(DIII) may disrupt the rapsyn interaction with endogenous
calpain, and thus release its inhibitory effect. As shown in
Figure 5A, the amount of m-calpain coprecipitated with
rapsyn was decreased in muscle cells expressing Myc-
DIII. As expected, expression of Myc-DIII in muscle cells
resulted in an increase of CCh-induced p25 production
(Figure 5B, lane 3, top panel). By contrast, Myc-DIV, whichdid not inhibit the rapsyn-calpain interaction (Figure 5A),
had no effect on p25 production (Figure 5B). To determine
whether the rapsyn-calpain interaction regulates AChR
clustering, wild-type or mutated forms of calpain were
overexpressed in C2C12 muscle cells. Transfected myo-
tubes, identified by anti-Myc antibody, were scored for
AChR clusters induced by agrin. The number and total
length of AChR clusters were significantly decreased in
C2C12 myotubes expressing Myc-DIII, but not Myc-DIV
(Figures 5C and 5D), suggesting a regulatory role of cal-
pain in agrin-induced formation of AChR clusters.
To investigate the effects of calpain on cluster stability,
transfected myotubes were first stimulated with agrin and
switched to agrin-free medium containing CCh to destabi-
lize AChR clusters. As shown in Figures 5F and 5H, the
CCh-induced declustering of AChR clusters was facili-
tated in muscle cells expressing m-calpain or DIII, but not
DIV, suggesting that the disruption of the rapsyn-calpainNeuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 253
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stimulation. Representative myotube images showing this
are seen in Figure 5E (top four sets). The reduction of
AChR cluster stability in calpain-transfected cells is in
line with the notion that calpain gain of function disturbs
AChR clusters. Remarkably, the effects of calpain or DIII
on CCh-induced declustering were abolished by treat-
ment with roscovitine (Ros), an inhibitor of Cdk5 (Figures
5G and 5I). Representative myotube images showing
this are seen in Figure 5E (bottom four sets). Taken to-
gether, these results suggest that the interaction of rapsyn
with calpain regulates AChR clustering by inhibiting Cdk5.
Calpain Inhibition Maintains AChR
Clusters in Agrin Mutant Mice
Having shown that calpain inhibition stabilized AChR clus-
ters in cultured muscle cells (Figure 2), we next investi-
gated the effect of calpain inhibition on synaptogenesis
in vivo (for the effect of calpeptin on the formation of AChR
clusters in cultured muscle cells, see the Supplemental
Results and Figure S2). Because inhibition of ChAT or
Cdk5 by genetic ablation or pharmacological inhibitors
(for Cdk5) has been shown to maintain AChR clusters in
agrin mutant mice (Lin et al., 2005; Misgeld et al., 2005),
we speculated that calpain inhibition should have a similar
effect if calpain functions in the same pathway. To test this
possibility, calpeptin was injected into pregnant mice daily
from E13.5 for 3 days. E16.5 diaphragm muscles of agrin
mutants (AGD/) (Burgess et al., 1999) or littermate wild-
Figure 6. Maintenance of AChRClusters in AgrinMutantMice
by Injecting Calpain Inhibitor
Calpeptin (15 mg/kg) or vehicle DMSO was injected i.p. into pregnant
mice (E13.5) daily for 3 days. Diaphragmmuscles of agrin mutant mice
(AGD/, [B] and [D]) or littermate control mice (+/+, [A] and [C]) at
E16.5 were dissected out and whole-mount stained with antibody
against synaptophysin to label presynaptic vesicles (green in insets),
along with R-BTX (red). AChR clusters in the most ventral region of
the left hemidiaphragm were analyzed. Scale bar, 100 mm.254 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.type controls were dissected out and stained for AChR
clusters. As shown in Figure 6B, few AChR clusters were
present in the muscle of AGD/ mice injected with vehi-
cle DMSO, compared to control (Figure 6A). However, nu-
merous AChR clusters were observed when AGD mutant
mice were treated with calpeptin (Figure 6D). Some of
these clusters were not apposed by nerve terminals pos-
itive for synaptophysin, a marker for presynaptic differen-
tiation (Figure 6D, inset; Figure S3, arrows). Quantitatively,
both average area of individual clusters and the number of
clusters were significantly increased in calpeptin-treated
AGD/ mice than that observed in DMSO-treated
AGD/ mice (Table 1 and Figure S3B). The rescue effect
of calpeptin was apparent in both the most ventral (Fig-
ure 6D) and dorsal regions (Figure S3) of diaphragm mus-
cles from AGD/ mice. Control littermates treated with
calpeptin also exhibited an increase in the number of
AChR clusters compared to DMSO-treated control mice
(Figures 6A and 6C, Figure S4, and Table 1). Interestingly,
the majority of AChR clusters of control mice either in-
jected with DMSO or calpeptin were colocalized with
nerve terminals stained positive for synaptophysin (Fig-
ures 6A and 6C, yellow in insets, and Figure S4), probably
due to the coincidence of post- and presynaptic differen-
tiation. These results suggest that inhibition of calpain is
important for the stabilization of AChR clusters. AChR
clusters can be formed independent of innervation (Lin
et al., 2001; Yang et al., 2001). The formation of these
aneural AChR clusters requires rapsyn and MuSK, but
not agrin (Lin et al., 2001; Yang et al., 2001). To explore
whether calpain inhibition has any effect on this prepat-
terned AChR clustering, we injected calpeptin daily into
pregnant mice from E10.5 for 4 days, and AChR clusters







Control (+/+) 34.0 ± 3.8 (149) 363 ± 22 (3)
AGD/ 12.4 ± 2.7 (28) 23 ± 3 (3)
Control (DMSO) 35.4 ± 5.0 (100) 369 ± 8 (3)
Control (calpeptin) 38.4 ± 5.0 (80) 456 ± 9a (3)
AGD/ (DMSO) 9.0 ± 1.6 (66) 36 ± 9 (3)
AGD/ (calpeptin) 17.7 ± 4.4b (61) 96 ± 13b (3)
CS Tg 34.6 ± 3.4 (119) 461 ± 23c (3)
CS Tg;AGD/ 23.8 ± 3.3d (64) 105 ± 13e (3)
Average area (mm2) of individual AChR clusters and number of
AChR clusters per field. Data are presented as mean ± SEM;
numbers in brackets indicate numbers of AChR clusters
(middle lane) measured or animals (right lane) evaluated.
a p < 0.01, compared with control (DMSO).
b p < 0.05, compared with AGD/ (DMSO).
c p < 0.01, compared with control (+/+).
d p < 0.05, compared with AGD/.
e p < 0.001, compared with AGD/.
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AChR clusters in AGD/ diaphragm muscles are visible.
We found that treatment with calpeptin resulted in a slight
increase in the proportion of large-sized clusters and the
formation of wider endplate in AGD/ mice. However,
these changes were not significant (Figure S5).
Overexpression of Calpastatin Maintains AChR
Clusters in Agrin Mutants
Since pharmacological inhibitors, including calpeptin,
may have potential side effects, we took advantage of cal-
pastatin, an endogenous protein inhibitor for calpain (Goll
et al., 2003), to further determine whether calpain acts to
disperse AChR clusters in vivo. Transgenic mice were
generated by overexpressing calpastatin under the con-
trol of the human skeletal actin (HSA) promoter (Figure 7A),
which has been shown to drive muscle-specific expres-
sion (Brennan and Hardeman, 1993; Luo et al., 2003).
Western blot showed that calpastatin was expressed at a
remarkable high level in skeletal muscles of the transgenic
mice (CS Tg) compared with wild-type control mice
(Figure 7B). Low expression of calpastatin was detectable
in other tissues, and this might be endogenous proteins
(Figure 7C). The expression level of calpastatin in themus-
cle of CS Tg mice was low at E14.5 and detectable at
E16.5 and gradually increased thereafter (Figure 7B). This
expression pattern of HSA-driven transgene is in agree-
ment with the promoter activity during development
(Brennan and Hardeman, 1993). The multiple bands in
CS Tg might be different types of calpastatin resulting
from both alternative splicing and proteolytic processing
(Takano et al., 1993). We found that the level of p25, an in-
dicator for calpain activity, in the skeletal muscle of CS Tg
mice was lower than that of control mice (Figure 7D, top
panel). By contrast, overexpression of calpastatin had
no effect on levels of other synaptic proteins including
rapsyn, MuSK, AChRa, and m-calpain (Figure 7D). The
relative activity of calpain was quantitatively estimated
by dividing the p25 level with the m-calpain level. We
found a significant decrease in the calpain activity in CS
Tg mice (Figure 7E).
Next we analyzed NMJ development of control or agrin-
deficient mice with calpastatin transgene. In agreement
with the observation that injection with calpeptin caused
an increase in the number of clusters in wild-type mice,
AChR clustering was also increased in CS Tg mice com-
pared with control littermates (Figures 7F and 7H and
Table 1). Importantly, numerous AChR clusters remained
in AGD/;CS Tg mice (Figure 7I), compared to control
AGD/ (Figure 7G). Quantitatively, both number and size
of AChR clusters were significantly higher in AGD/;CS
Tg mice when compared with AGD mutants (Figures 7J
and 7K and Table 1). This difference was remarkable not
only at various embryonic stages, i.e., E16.5 and E17.5
(Figures 7J and 7K; Figure S6), but also in different parts
of diaphragms, ranging from the most ventral to most dor-
sal regions (for the analysis of ventral regions, see Figures
7F–7K and Table 1; for the analysis of dorsal regions, seeFigure S7). As shown in Figures 7F–7K and Figure S6,
fewer AChR hotspots remained in AGD/ mice at E17.5
compared with E16.5; overexpression of calpastatin
markedly increased the AChR clusters at E17.5 as well
as E16.5. However, the rescue effect at E17.5 appeared
to be not more profound than that at E16.5 (see Figures
7J and 7K, compare the fold increase of cluster numbers
and area in AGD/;CS Tg mice to that of AGD/ mice
at E16.5 and E17.5, for numbers: 4.5- ± 0.6-fold at E16.5
versus 4.1- ± 1.1-fold at E17.5, for area: 1.9- ± 0.2-fold
at E16.5 versus 2.0- ± 0.4-fold at E17.5), although the
expression of calpastatin in CS Tg mice gradually in-
creased during development (Figure 7B). It is possible
that there are other dispersing factors that act to disas-
semble AChR clusters independent of calpain. Unlike
AGD/Cdk5 or AGD/ChAT double mutants, where presyn-
aptic differentiation was apparent compared to AGD sin-
gle mutant mice (Lin et al., 2005), most AChR clusters in
AGD/;CS Tg mice were not apposed by presynaptic
nerve terminals (see inset in Figure 7I, and Figure S6,
arrows). Thus calpain inhibition in the skeletal muscle in-
creased AChR clusters in agrin mutants, but had no effect
on presynaptic differentiation.
DISCUSSION
The present study uncovers a role of calpain, a family of
calcium-dependent protease, in regulating postsynaptic
differentiation at the NMJ. Cholinergic activation stimu-
lates calpain, whose inhibition stabilizes AChR clusters
in culturedmuscle cells and in agrin mutant mice. Interest-
ingly, rapsyn interacts with calpain and inhibits calpain
activity. Blockade of the rapsyn-calpain interaction en-
hances CCh-induced AChR cluster dispersal. Further-
more, agrin increases rapsyn interaction with calpain and
inhibits CCh-induced calpain activation. One substrate of
calpain may be p35, whose cleavage by calpain generates
p25, a potent activator of Cdk5 (Ahlijanian et al., 2000; Pat-
rick et al., 1999; Patzke et al., 2003). Cdk5 inhibition coun-
teracts the effects of calpain on AChR cluster dispersal.
Together, these results support a model depicted in Fig-
ure 8 supporting the following hypothesis: AChR clusters
are dispersed in muscle cells by electric activity stimu-
lated by cholinergic inputs; agrin stimulates the interaction
of rapsyn, which is spatially localized in synapses, with
calpain to inhibit its enzyme activity to allow for formation
of new AChR clusters and/or maintenance of existing
AChR clusters.
Activation of AChRs leads to calcium influx via the li-
gand-gated ion channel (i.e., AChRs) or indirectly via so-
dium influx-stimulated calcium from intracellular stores
(Allard et al., 1996; Cherednichenko et al., 2004). How-
ever, the role of calcium in AChR clustering is complex
(Bloch, 1983; Megeath and Fallon, 1998; Tseng et al.,
2003). How calcium acts to alter the stability of AChR clus-
ters is yet to be investigated. Calpain is a family of prote-
ases that are activated by calcium. Our findings in this pa-
per suggest a role of calpain in regulating AChR clusters.Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 255
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Rapsyn Inhibits CalpainFigure 7. The Loss of AChR Clusters in Agrin Mutant Mice Is Prevented by Overexpressing Calpastatin
(A) Construct for the generation of calpastatin transgenic mice. HSA, human skeletal actin promoter.
(B) Developmental expression of calpastatin in the skeletal muscle of transgenic mice. Homogenates of the skeletal muscle from calpastatin trans-
gene (CS Tg) or littermate wild-type control mice at different developmental stages, embryonic day 14.5 (E14.5) to postnatal day 0 (P0), were probed
for expression of calpastatin or loading controls.
(C) Muscle-specific expression of calpastatin transgene. Same amounts of proteins from various tissues were probed for the level of calpastatin,
using b-actin as control.
(D) Decreased p25 levels in CS Tg mice. Same amounts of proteins isolated from skeletal muscles of CS Tg or control mice at E18.5 were probed for
the level of p25 and other indicated proteins.
(E) Decreased calpain activity in CS Tgmice. The level of p25 normalizedwithm-calpain reflects relative activity of calpain frommice skeletal muscles.
The calpain activity of control mice was taken as 1.0. Data are shown as mean ± SEM (n = 4 for control and n = 7 for CS Tg; ***p < 0.001; Student’s
t test).
(F–I) Representative images of AChR clusters and nerve terminals from the most ventral sides of mice diaphragmmuscles. E16.5 diaphragmmuscles
from control (+/+) (F), AGD/ (G), CS Tg (H), and AGD/;CS Tg (I) mice were double stained with R-BTX (red) and anti-synaptophysin antibody
(green). Scale bar, 100 mm.256 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.
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Rapsyn Inhibits CalpainBy using a specific substrate or probing the levels of p25
to monitor calpain activity, we show that CCh causes
calpain activation (Figure 1). Furthermore, inhibition of cal-
pain stabilizes AChR clusters in vitro (Kim and Nelson,
2000) (Figure 2) and in vivo (Figures 6 and 7), whereas
overexpression of calpain promotes cluster dispersal (Fig-
ure 5). These results indicate a negative role of calpain in
AChR clustering. One possible target of calpain is Cdk5,
which is activated by CCh in cultured muscle cells and
whose ablation leads to enlarged AChR clusters (Fu et al.,
2005; Lin et al., 2005). This notion is supported by the
following observations. First, CCh-induced Cdk5 activa-
tion was dependent on calpain. Second, CCh treatment
caused the accumulation of p25, a potent activator of
Cdk5. Third, overexpression of calpain promoted CCh-in-
duced AChR cluster dispersion, whichwas ameliorated by
inhibition of Cdk5. In addition to p25, calpain may also
have other substrates. Several molecules have been iden-
tified to function downstream of agrin/MuSK signaling to
induce AChR clustering (Luo et al., 2002, 2003; Okada
et al., 2006; Wang et al., 2003; Weston et al., 2000). It is
possible that calpain may also cleave other substrates to
destabilize AChR clusters. We note that Cdk5 activation
happens shortly after ‘‘cholinergic’’ stimulation (Lin et al.,
2005) (data not shown), whereas the production of p25
happens slowly (Figure 1). This suggests that other events,
such as phosphorylation modifications (Hallows et al.,
2003; Sharma et al., 1999), may also contribute to Cdk5
activation.
Intracellular calcium elevation, elicited by synaptic ac-
tivity, stimulates calpain, which has been implicated in
regulating the integrity and localization of synaptic pro-
teins, and synaptic plasticity (Lee et al., 2000; Lynch and
Figure 8. The Working Hypothesis
ACh activates Cdk5 in a manner dependent on calpain. Activated
Cdk5 disperse AChR clusters. Agrin increases the interaction of rapsyn
with calpain and thus inhibits calpain activity to stabilize AChR clusters
at synapses.Seubert, 1989; Patrick et al., 1999; Siman and Noszek,
1988). Calpain activity is regulated by multiple mecha-
nisms including phosphorylation, autolysis, and interac-
tion with phospholipids (Carafoli andMolinari, 1998; Glad-
ing et al., 2002). In addition, calpain activity is also
regulated by interacting proteins, mainly calpastatin (Ben-
etti et al., 2001; Carafoli and Molinari, 1998; Glading et al.,
2002). Here we identified rapsyn as a regulator for calpain.
Rapsyn is a peripheral membrane protein that is essential
for AChR clustering and neuromuscular junction formation
(Gautam et al., 1995; Lin et al., 2001; Phillips et al., 1991a,
1991b; Qu et al., 1996). This protein is thought to function
downstream of the agrin/MuSK signaling, leading to AChR
clustering (Apel et al., 1997). The present study reveals an
unexpected mechanism by which rapsyn regulates AChR
clusters. Rapsyn interacts with calpain and inhibits calpain
activity in vitro and in vivo. The region in calpain for rapsyn
interaction is domain III, a region that is known to regulate
calpain activity (Hosfield et al., 2001; Rizo and Sudhof,
1998; Tompa et al., 2001). Disruption of the rapsyn-cal-
pain interaction activates calpain and promotes AChR
cluster dispersal. Remarkably, p25 levels, which reflect
calpain activity, at the synaptic region are lower than that
of nonsynaptic region (Figure 4I), supporting the conclu-
sion that calpain is spatially inhibited at the NMJ, most
probably by agrin and rapsyn. In agreement with this no-
tion, inhibition of calpain partially prevented the loss of
AChR clusters in agrin mutant mice (Figures 6 and 7). Re-
cently it has been shown that inhibition or ablation of
Cdk5 or ablation of ChAT had a similar rescue effect (Lin
et al., 2005; Misgeld et al., 2005). In addition to the rescue
phenotypes, AGD/ChAT double mutants had increased
presynaptic differentiation, and all AChR clusters were
opposed by synaptic nerve terminals in AGD/ChAT or
AGD/Cdk5/ mice (Lin et al., 2005; Misgeld et al., 2005).
However, this phenotype was not observed in AGD/;CS
Tg mice, probably due to the muscle-specific expression
of calpastatin. It is possible that the presynaptic pheno-
types of ChAT or Cdk5 mutant mice were caused by the
ablation of these genes in motor neurons.
Taken together, the inhibitory effect of calpain, acti-
vated by cholinergic activation, could be reversed by
agrin, which inhibits calpain by increasing its interaction
with rapsyn. This study provides insight into the role of
rapsyn in synapse formation and reveals a mechanism
of the agrin pathway. It will shed light on the regulatory
mechanism for calpain in CNS synaptogenesis.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies
Double-stranded oligonucleotides targeting against rapsyn or m-cal-
pain were synthesized by Shanghai GenePharma Co.LTD. The siRNA
sequence was designed against a region starting from 233 or 270 nt of
mouse rapsyn cDNA. The sequence of #233 is 50-ATGCTGACTTCC(J and K) Quantitation of AChR clusters. The average area of individual clusters and number of clusters in the same field of themost ventral sides of left
diaphragmmuscles from E16.5 or E17.5 mice are shown in (J) and (K), respectively. Data are presented as mean ± SEM (n = 3; *p < 0.05, ***p < 0.001,
Student’s t test). The following numbers of clusters were analyzed for average area: 40 for AGD/ and 50 for AGD/;CS Tg (E17.5).Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc. 257
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(reverse). The sequence of #270 is 50-GCGCAGCAATGAGAAGCT
ATG-30 (forward) and 50-CATAGCTTCTCATTGCTGCGC-30 (reverse).
The sequence of m-calpain siRNA is 50-GGATGGCGATTTCTGC
ATC-30 (forward) and 50-GATGCAGAAATCGCCATCC-30 (reverse).
The control (nonsilencing) siRNA was purchased from QIAGEN-Xera-
gon, and it does not target any known mammalian gene (the targeted
sequence is 50-AATTCTCCGAACGTGTCACGT-30). Rabbit antisera
were generated against the GST-rapsyn C terminus (aa 354–412) or
m-calpain domain IV (aa 510–700).Monoclonal anti-rapsynwas gener-
ously provided by Stan Frohner. Other antibodies were fromChemicon
(b-actin), Santa Cruz (CDK5, p35, GFP), BD/Clontech (b-catenin, Myc),
and Sigma (HA,MHC). The calpain inhibitor calpeptin was fromCalbio-
chem, R-BTX was from Molecule Probes, agrin was from R&D, gluta-
thione-sepharose was from Amersham Pharmacia, and protein A or
protein G agarose was from Roche.
Constructs
Rapsyn was subcloned into pEGFP-N1 in frame with EGFP. Different
domains of rapsyn were inserted into pKH3 with 3xHA epitopes at the
N-terminus: TPRs (aa 1–320), coiled-coil (aa 290–360), and RING-H2
(aa 354–412). m-Calpain mutants (domain III, aa 350–515; domain IV,
aa 510–700) were subcloned into pCS2 + MT in frame with 6xMyc epi-
topes at the N terminus, or into pGEX-2T to produce GST-fusion pro-
teins. HA-calpain was described previously (Benetti et al., 2001). p35
and Cdk5 cDNA were obtained with reverse transcription-PCR using
rat brain total RNA as template and subcloned into pCS2 + MT and
pKH3, respectively.
Cell Culture, Transfection, and Biochemical Characterization
HEK293 cells and C2C12muscle cells were cultured as described (Luo
et al., 2002). Cells were transfected by the standard calcium phos-
phate method or with FuGENE6 (Roche) following the manufacturer’s
instruction. Cell lysates were prepared in the modified RIPA buffer
including protease inhibitors (Luo et al., 2003). For pull-down assay,
cell lysates (0.5–1.0 mg protein/ml) were incubated with 5 mg GST-fu-
sion protein immobilized on sepharose beads for 4 hr at 4C. Bound
proteins were resolved by SDS-PAGE. For immunoprecipitation, ly-
sates (0.3–0.5 mg of protein in a final volume of 1 ml) were incubated
with respective antibodies (2.5–3 mg) and subsequently with 40 ml pro-
tein A or protein G agarose beads. Immunoprecipitated proteins were
resolved by SDS-PAGE and subsequent immunoblotting. All experi-
ments were repeated at least three times.
Calpain Activity Assay
Calpain activity was measured using Suc-Leu-Tyr-7-amino-4-methyl-
coumarin (Suc-Leu-Tyr-AMC) as the substrate (Chen et al., 2001).
C2C12 myotubes were treated with DMSO or 0.1 mM CCh, without
or with 20 mM calpeptin for indicated time. Cell lysates (100 mg of pro-
tein) were added to 100 ml reaction buffer (145 mMNaCl, 100 mM Tris-
HCl [pH 7.3]) containing 80 mM Suc-Leu-Tyr-AMC and reacted for
30 min at room temperature. The amount of AMC release resulting
from calpain cleavage was determined by measuring the value of fluo-
rescence (excitation at 360 nmand emission at 460 nm) using aGENios
fluorescence system. All measurements were performed in triplicate.
Generation of Transgenic Mice Overexpressing Calpastatin
in the Skeletal Muscle
The human calpastatin cDNA was inserted between the NotI and PacI
site of plasmid pBSX-HSAvpA downstream of the HSA promoter/VP1
intron. The HSA-calpastatin fragment was excised using KpnI and
NaeI, gel purified, and microinjected into C57BL/6JxSJL fertilized
eggs, which were then reimplanted into pseudopregnant recipient
mice. Primer 1 covers the initial methionine: 50-ATAAGAATGCGG
CCGCATGAATCCCACAGAAACCAAGGC-30; primer 2 covers the
stop codon: 50-CCTTAATTAACTAGTCATCTTTTGGCTTGGAAGTTT-30.
Calpastatin transgenic mice (CS Tg) were genotyped by PCR anal-258 Neuron 55, 247–260, July 19, 2007 ª2007 Elsevier Inc.ysis of mice tail DNA. The transgenic mice were fertile and did not
show gross anatomic defects within 6 months of observation after
birth. Morphologically, muscle fibers revealed grossly normal architec-
ture similar to that of control mice (data not shown). To determine
transgene expression at the protein level, skeletal muscle and other
tissues were sliced and sonicated in extraction buffer (modified RIPA
containing 1 mM DTT and protease inhibitors) and then subjected to
ultracentrifugation (150,000 g). Aliquots of supernatants were sub-
jected to Western blotting using anti-calpastatin antibody. CS Tg
mice were crossed with agrin mutant mice (AGD/) to generate the
mice with agrin deficiency and calpastatin overexpression.
Immunohistochemistry
Frozen sections of muscle or cells in culture were stained with indi-
cated antibodies, washed, and incubated with FITC-conjugated goat
anti-rabbit or anti-mouse antibody, and together with tetramethylrhod-
amine-a-bangarotoxin (R-BTX) to label the AChR (Luo et al., 2003).
Images were collected with a Zeiss confocal microscope using
a 403 objective. The total length of all AChR clusters or number of
clusters bigger than 5 mm in 100 mmmyotubes were quantitatively an-
alyzed. For diaphragm samples, staining procedure was followed as
shown in the previous study (Luo et al., 2003). Synaptic nerve terminals
were marked by staining with anti-synaptophysin antibody. AChR
clusters labeled by R-BTX at themost ventral left side of the diaphragm
that has little anatomical variation across mice were quantitatively
analyzed. In some cases, AChR clusters at dorsal regions were also
analyzed.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/2/247/DC1/.
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